Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis
Condition(s):Rifampicin Susceptible Pulmonary TuberculosisLast Updated:October 10, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Rifampicin Susceptible Pulmonary TuberculosisLast Updated:October 10, 2023Recruiting
Condition(s):Tuberculosis; Uveitis (Manifestation); Anti-Tuberculous Drug Reaction; Tuberculous UveitisLast Updated:February 28, 2024Recruiting
Condition(s):Multidrug Resistant TuberculosisLast Updated:July 30, 2018Not yet recruiting
Condition(s):Tuberculosis Meningitis; HIV-1-infectionLast Updated:September 28, 2021Completed
Condition(s):Tuberculosis, PulmonaryLast Updated:February 13, 2020Completed
Condition(s):HIV Infections; TuberculosisLast Updated:November 3, 2021Completed
Condition(s):Pulmonary TuberculosisLast Updated:March 23, 2020Completed
Condition(s):Tuberculosis; Alcohol Consumption; Treatment Adverse EffectLast Updated:November 2, 2023Completed
Condition(s):Tuberculosis; Multidrug Resistant Tuberculosis; Extensively-drug Resistant TuberculosisLast Updated:September 29, 2021Completed
Condition(s):Pulmonary Disease Due to Mycobacteria (Diagnosis)Last Updated:August 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.